Related Experiment Videos
[Hypothyroid cardiomyopathy--an underdiagnosed cause of heart failure]
T Gundersen1, A Q Paulsen, F Gallefoss
1Medisinsk avdeling, Aust-Agder Sentralsjukehus, Adrendal.
Insights
Thyroid hormone replacement therapy effectively reverses cardiac changes in hypothyroid cardiomyopathy. Treatment with thyroxin reduced interventricular septum thickness and resolved pericardial effusion in patients with heart failure.
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Abstract:
20 patients with hypothyroid cardiomyopathy were evaluated by M-mode echocardiography. The mean interventricular septum (IVSd) thickness was 1.94 cm before treatment and was reduced to 1.21 cm after 4-6 months of thyroxin therapy. The mean left ventricular posterior wall (LVPWd) thickness was 1.14 cm before and 1.05 cm after treatment. The IVS/LVPW ratio decreased from 1.7 to 1.15 within 4-6 months. Pericardial effusion was demonstrated in 15 of the patients, but disappeared during thyroxin therapy. The study confirms the importance of examining for hypothyreoidism in the case of patients with symptoms of heart failure of unknown cause, and of patients with echocardiographic evidence of asymmetric septal hypertrophy (ASH) and idiopathic hypertrophic subaortic stenosis (IHSS).